South & Central America Brain Implants Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Treatment [Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulator, Invasive and Non-Invasive Brain-Computer Interface, Responsive Neurostimulation for Seizures, Auditory Brainstem Implant (Retrocochlear Hearing Impairment and Cochlear Hearing Impairment), and Ophthalmic Aid/Implant], Application [Chronic Pain, Parkinson\'s Disease, Alzheimer\'s Disease, Epilepsy, Essential Tremor, Depression, Dystonia, Amyotrophic Lateral Sclerosis (ALS), and Neurofibromatosis 2], and End User (Hospitals and Specialized Clinics/Neurological Centers)


No. of Pages: 82    |    Report Code: BMIRE00029803    |    Category: Life Sciences

South & Central America Brain Implants Market
Buy Now

The South & Central America brain implants market was valued at US$ 366.05 million in 2022 and is expected to reach US$ 730.98 million by 2030; it is estimated to grow at a CAGR of 9.0% from 2022 to 2030.



Strategic Initiatives by Companies Fuels South & Central America Brain Implants Market

Companies operating in the brain implants market constantly focus on strategic developments such as product approvals, collaborations, expansions, agreements, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. For example, in December 2022, Abbott launched the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable, rechargeable SCS system available on the market for the treatment of chronic pain. The company's portfolio of neuromodulation devices also includes Proclaim XR, the recharge-free SCS system, and Proclaim Plus featuring FlexBurst360.

Brain implant manufacturers are taking steps to expand their operations around the world and launch their products in different regions, which is expected to boost the market penetration and accessibility of their offerings. Therefore, product introduction and strategic moves such as approvals, expansions, and acquisitions create significant growth opportunities in the South & Central America brain implants market.

South & Central America Brain Implants Market Overview

The South & Central America brain implants market is segmented into Brazil, Argentina, and the Rest of South & Central America. South & Central America will likely account for over 9.0% of the brain implant market during 2022-2030. The prevalence of neurological disorders, such as Parkinson's disease and Alzheimer's disease, has been linked to the aging population in Brazil. According to the data from the Pan American Health Organization (PAHO), Brazil has over 30 million people aged 60 years and above, representing 13% of the country's population. By 2030, this age group is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazilian Institute of Country and Statistics, the country's population aged 65 and above is expected to hold a 36% share of the total population of Brazil by 2050. As per the study, "Trends in mortality from Alzheimer's disease in Brazil, 2000-2019," published in 2023, in Brazil, Alzheimer's disease has become a major health concern since the population is increasingly aging, coupled with the increasing mortality rates and the growing prevalence of the disease in the country in recent years. There was a 49% increase in deaths due to Alzheimer's disease between 2009 and 2019 in the country, making it the seventh leading cause of death. More than 211,600 deaths were due to Alzheimer's disease in the same period in Brazil, 64% of which were female. Furthermore, 73% of the deaths were related to people aged 80 and above, and 27% were in the 60-79 age group. Thus, the abovementioned factors are expected to increase the demand for brain implants for the treatment of these neurological diseases in the country in the coming years.

South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Brain Implants Market Segmentation

The South & Central America brain implants market is segmented into treatment, application, end user, and country.

Based on treatment, the South & Central America brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held the largest share in 2022. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.

In terms of application, the South & Central America brain implants market is categorized into chronic pain, Parkinson's disease, Alzheimer's disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.

Based on end user, the South & Central America brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.

Based on country, the South & Central America brain implants market is segmented Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America brain implants market in 2022.

Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Renishaw Plc are some of the leading companies operating in the South & Central America brain implants market.


South & Central America Brain Implants Strategic Insights

Strategic insights for the South & Central America Brain Implants provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/south-and-central-america-brain-implants-market-strategic-framework.webp
Get more information on this report

South & Central America Brain Implants Report Scope

Report Attribute Details
Market size in 2022 US$ 366.05 Million
Market Size by 2030 US$ 730.98 Million
Global CAGR (2022 - 2030) 9.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Treatment
  • Deep Brain Stimulation
  • Spinal Cord Stimulation
  • Vagus Nerve Stimulator
  • Invasive and Non-Invasive Brain-Computer Interface
  • Responsive Neurostimulation for Seizures
  • Auditory Brainstem Implant
  • Ophthalmic Aid/Implant
By Application
  • Chronic Pain
  • Parkinson's Disease
  • Alzheimer's Disease
  • Epilepsy
  • Essential Tremor
  • Depression
  • Dystonia
  • Amyotrophic Lateral Sclerosis
  • Neurofibromatosis 2
By End User
  • Hospitals and Specialized Clinics/Neurological Centers
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Abbott Laboratories
  • Boston Scientific Corp
  • Medtronic Plc
  • Renishaw Plc
  • Get more information on this report

    South & Central America Brain Implants Regional Insights

    The geographic scope of the South & Central America Brain Implants refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/south-and-central-america-brain-implants-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Brain Implants Market

    1. Abbott Laboratories

     

    2. Boston Scientific Corp

    3. Medtronic Plc

    4. Renishaw Plc

    Frequently Asked Questions
    How big is the South & Central America Brain Implants Market?

    The South & Central America Brain Implants Market is valued at US$ 366.05 Million in 2022, it is projected to reach US$ 730.98 Million by 2030.

    What is the CAGR for South & Central America Brain Implants Market by (2022 - 2030)?

    As per our report South & Central America Brain Implants Market, the market size is valued at US$ 366.05 Million in 2022, projecting it to reach US$ 730.98 Million by 2030. This translates to a CAGR of approximately 9.0% during the forecast period.

    What segments are covered in this report?

    The South & Central America Brain Implants Market report typically cover these key segments-

    • Treatment (Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulator, Invasive and Non-Invasive Brain-Computer Interface, Responsive Neurostimulation for Seizures, Auditory Brainstem Implant, Ophthalmic Aid/Implant)
    • Application (Chronic Pain, Parkinson\'s Disease, Alzheimer\'s Disease, Epilepsy, Essential Tremor, Depression, Dystonia, Amyotrophic Lateral Sclerosis, Neurofibromatosis 2)
    • End User (Hospitals and Specialized Clinics/Neurological Centers)

    What is the historic period, base year, and forecast period taken for South & Central America Brain Implants Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Brain Implants Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in South & Central America Brain Implants Market?

    The South & Central America Brain Implants Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • Boston Scientific Corp
  • Medtronic Plc
  • Renishaw Plc
  • Who should buy this report?

    The South & Central America Brain Implants Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Brain Implants Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    south-and-central-america-brain-implants-market